CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells

Experimental Hematology

Volumn 32, Issue 4, 2004, Pages 382-389

  Hübinger, Gabriele ^a   Schneider, Christof ^a,c   Stöhr, Dagmar ^a   Ruff, Heike ^a   Kirchner, Dieter ^a   Schwänen, Carsten ^a   Schmid, Mathias ^a   Bergmann, Lothar ^b   Müller, Elke ^a  

^a UNIVERSITY OF ULM   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CYTOKINE RECEPTOR; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL LINE; CELL VIABILITY; CIAP1 GENE; CIAP2 GENE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD30; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHOMA, LARGE-CELL; NEOPLASM PROTEINS; NF-KAPPA B; PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 1642587842     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.01.003     Document Type: Article

References (46)

1. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:1994;959-962.
2. Baker S.J., Reddy E.P. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene. 12:1996;1-9.
3. Baker S.J., Reddy E.P. Modulation of life and death by the TNF receptor superfamily. Oncogene. 17:1998;3261-3270.
4. Baxter G.T., Kuo R.C., Jupp O.J., Vandenabeele P., MacEwan D.J. Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem. 274:1999;9539-9547.
5. Screaton G., Xu X.N. T cell life and death signalling via TNF-receptor family members. Curr Opin Immunol. 12:2000;316-322.
6. Ware C.F., VanArsdale S., VanArsdale T.L. Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem. 60:1996;47-55.
7. Ashkenazi A., Dixit V.M. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 11:1999;255-260.
8. Schwab U., Stein H., Gerdes J., et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature. 299:1982;65-67.
9. Chiarle R., Podda A., Prolla G., Gong J., Thorbecke G.J., Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol. 90:1999;157-164.
10. Durkop H., Foss H.D., Eitelbach F., et al. Expression of the CD30 antigen in non-lymphoid tissues and cells. J Pathol. 190:2000;613-618.
11. Croager E.J., Gout A.M., Abraham L.J. Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene. Am J Pathol. 156:2000;1723-1731.
12. Stein H., Foss H.D., Durkop H., et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 96:2000;3681-3695.
13. Kadin M.E. Regulation of CD30 antigen expression and its potential significance for human disease. Am J Pathol. 156:2000;1479-1484.
14. Gedrich R.W., Gilfillan M.C., Duckett C.S., Van Dongen J.L., Thompson C.B. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J Biol Chem. 271:1996;12852-12858.
15. Lee S.Y., Lee S.Y., Kandala G., Liou M.L., Liou H.C., Choi Y. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. Proc Natl Acad Sci USA. 93:1996;9699-9703.
16. Lee S.Y., Lee S.Y., Choi Y. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation. J Exp Med. 185:1997;1275-1285.
17. Duckett C.S., Gedrich R.W., Gilfillan M.C., Thompson C.B. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol Cell Biol. 17:1997;1535-1942.
18. Horie R., Aizawa S., Nagai M., et al. A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation. Int Immunol. 10:1998;203-210.
19. Pype S., Declercq W., Ibrahimi A., et al. TTRAP, a novel protein that associates with CD40, tumor necrosis factor receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J Biol Chem. 275:2000;18586-18593.
20. Tian Z.G., Longo D.L., Funakoshi S., et al. In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenografts. Cancer Res. 55:1995;5335-5341.
21. + anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1). Am J Pathol. 155:1999;1353-1359.
22. Hübinger G., Scheffrahn I., Müller E., et al. The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation. Exp Hematol. 27:1999;1796-1805.
23. Hübinger G., Müller E., Scheffrahn I., et al. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299. Oncogene. 20:2001;590-598.
24. Hsu P.L., Hsu S.M. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma. Lab Invest. 80:2000;1111-1119.
25. Mir S.S., Richter B.W., Duckett C.S. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells. Blood. 96:2000;4307-4312.
26. Duckett C.S., Thompson C.B. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11:1997;2810-2821.
27. Grell M., Zimmermann G., Gottfried E., et al. Induction of cell death by tumor necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18:1999;3034-3043.
28. Friesen C., Herr I., Krammer P.H., Debatin K.M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med. 2:1996;574-577.
29. Schneider C., Hübinger G. Pleiotropic signal transduction mediated by human CD30, a member of the tumor necrosis factor receptor (TNFR) family. Leuk Lymphoma. 43:2002;1355-1366.
30. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs)-a family of adapter proteins that regulates life and death. Genes Dev. 12:1998;2821-2830.
31. Levi E., Wang Z., Petrogiannis-Haliotis T. et al. Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression. J Invest Dermatol. 115:2000;1034-1040.
32. Muta H., Boise L.H., Fang L., Podack E.R. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis. J Immunol. 165:2000;5105-5111.
33. Deveraux Q.L., Reed J.C. IAP family proteins: suppressors of apoptosis. Genes Dev. 13:1999;239-252.
34. Roy N., Deveraux Q.L., Takashashi R., Salvesen G.S., Reed J.C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of caspases. EMBO J. 16:1997;6914-6925.
35. Deveraux Q.L., Roy N., Stennicke H.R., et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17:1998;2215-2223.
36. Roy N., Deveraux Q.L., Takashashi R., Salvesen G.S., Reed J.C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of caspases. EMBO J. 16:1997;6914-6925.
37. Dubrez L., Goldwasser F., Genne P., Pommier Y., Solary E. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia. 9:1995;1013-1024.
38. Dubrez L., Savoy I., Hamman A., Solary E. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 15:1996;5504-5512.
39. Seidemann K., Tiemann M., Schrappe M., et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 97:2001;3699-3706.
40. Chu Z.L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl Acad Sci. 94:1997;10057-10062.
41. Stehlik C., de Martin R., Kumabshiri I., Schmid J.A., Binder B.R., Lipp J. Nuclear factor (NF)-κB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J Exp Med. 188:1998;211-218.
42. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF3 and c-IAP1 and c-IAP2 to suppress caspase-8 activity. Science. 1998;1680-1683.
43. Lacasse E.C., Baird S., Korneluk R.G., MacKenzie A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 17:1998;3247-3259.
44. Lee K.Y., Chang W., Qui D., Kao P.N., Rosen G.D. PG490 (triptolide) cooperates with tumor necrosis factor-α to induce apoptosis in tumor cells. J Biol Chem. 274:1999;13451-13455.
45. Rothe M., Wong S.C., Henzel W.J., Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
46. Wahl C., Liptay S., Adler G., Schmid R.M. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 101:1998;1163-1174.